Arnold DL - Search Results

1

Pegylated interferon β-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study.

Calabresi PA, Kieseier BC, Arnold DL, Balcer LJ, Boyko A, Pelletier J, Liu S, Zhu Y, Seddighzadeh A, Hung S, Deykin A; ADVANCE Study Investigators. Calabresi PA, et al. Among authors: arnold dl. Lancet Neurol. 2014 Jul;13(7):657-65. doi: 10.1016/S1474-4422(14)70068-7. Epub 2014 Apr 30. Lancet Neurol. 2014. PMID: 24794721 Clinical Trial.

2

Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis.

Matthews PM, Francis G, Antel J, Arnold DL. Matthews PM, et al. Among authors: arnold dl. Neurology. 1991 Aug;41(8):1251-6. doi: 10.1212/wnl.41.8.1251. Neurology. 1991. PMID: 1650931

3

Short-term dichloroacetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders.

De Stefano N, Matthews PM, Ford B, Genge A, Karpati G, Arnold DL. De Stefano N, et al. Among authors: arnold dl. Neurology. 1995 Jun;45(6):1193-8. doi: 10.1212/wnl.45.6.1193. Neurology. 1995. PMID: 7783888 Clinical Trial.

4

Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis.

Arnold DL, Riess GT, Matthews PM, Francis GS, Collins DL, Wolfson C, Antel JP. Arnold DL, et al. Ann Neurol. 1994 Jul;36(1):76-82. doi: 10.1002/ana.410360115. Ann Neurol. 1994. PMID: 8024266

5

Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy.

Matthews PM, Pioro E, Narayanan S, De Stefano N, Fu L, Francis G, Antel J, Wolfson C, Arnold DL. Matthews PM, et al. Among authors: arnold dl. Brain. 1996 Jun;119 ( Pt 3):715-22. doi: 10.1093/brain/119.3.715. Brain. 1996. PMID: 8673485

6

Axonal dysfunction and disability in a relapse of multiple sclerosis: longitudinal study of a patient.

De Stefano N, Matthews PM, Narayanan S, Francis GS, Antel JP, Arnold DL. De Stefano N, et al. Among authors: arnold dl. Neurology. 1997 Oct;49(4):1138-41. doi: 10.1212/wnl.49.4.1138. Neurology. 1997. PMID: 9339704

7

Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study.

De Stefano N, Matthews PM, Fu L, Narayanan S, Stanley J, Francis GS, Antel JP, Arnold DL. De Stefano N, et al. Among authors: arnold dl. Brain. 1998 Aug;121 ( Pt 8):1469-77. doi: 10.1093/brain/121.8.1469. Brain. 1998. PMID: 9712009

8

Relating axonal injury to functional recovery in MS.

Reddy H, Narayanan S, Matthews PM, Hoge RD, Pike GB, Duquette P, Antel J, Arnold DL. Reddy H, et al. Among authors: arnold dl. Neurology. 2000 Jan 11;54(1):236-9. doi: 10.1212/wnl.54.1.236. Neurology. 2000. PMID: 10636158

9

Heterogeneity of T-lymphocyte function in primary progressive multiple sclerosis: relation to magnetic resonance imaging lesion volume.

Prat A, Pelletier D, Duquette P, Arnold DL, Antel JP. Prat A, et al. Among authors: arnold dl. Ann Neurol. 2000 Feb;47(2):234-7. Ann Neurol. 2000. PMID: 10665495

10

Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b.

Narayanan S, De Stefano N, Francis GS, Arnaoutelis R, Caramanos Z, Collins DL, Pelletier D, Arnason BGW, Antel JP, Arnold DL. Narayanan S, et al. Among authors: arnold dl. J Neurol. 2001 Nov;248(11):979-86. doi: 10.1007/s004150170052. J Neurol. 2001. PMID: 11757963 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

542 results

Search Page

Filters